Basit öğe kaydını göster

Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries

dc.contributor.authorCeylan, Bahadır
dc.contributor.authorAslan, Ferhat
dc.contributor.authorYardımcı, Cem
dc.contributor.authorFincancı, Muzaffer
dc.contributor.authorÖzgüneş, Nail
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:52:29Z
dc.date.available10.07.201910:49:13
dc.date.available2019-07-10T19:52:29Z
dc.date.issued2014en_US
dc.identifier.citationCeylan, B., Aslan, F., Yardımcı, C., Fincancı, M. ve Özgüneş, N. (2014). Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries. European Journal of Gastroenterology & Hepatology, 26(4), 493-494. https://dx.doi.org/10.1097/MEG.0000000000000054en_US
dc.identifier.issn0954-691X
dc.identifier.issn1473-5687
dc.identifier.urihttps://dx.doi.org/10.1097/MEG.0000000000000054
dc.identifier.urihttps://hdl.handle.net/20.500.12511/2409
dc.descriptionWOS: 000332604700021en_US
dc.descriptionPubMed ID: 24598385en_US
dc.description.abstractThe current treatment for chronic hepatitis C virus (HCV) infection in Turkey is pegylated interferon (IFN) plus ribavirin combination. Patients who developed relapse following the first pegylated IFN plus ribavirin combination treatment are recommended to be treated by regimes in which protease inhibitors are combined with pegylated IFN plus ribavirin [1,2].en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectPegylated Interferonen_US
dc.subjectRibavirin Combination Treatmenten_US
dc.subjectHepatitis C Virusen_US
dc.titleEfficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countriesen_US
dc.typeletteren_US
dc.relation.ispartofEuropean Journal of Gastroenterology & Hepatologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.identifier.volume26en_US
dc.identifier.issue4en_US
dc.identifier.startpage493en_US
dc.identifier.endpage494en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.1097/MEG.0000000000000054en_US
dc.identifier.wosqualityQ4en_US
dc.identifier.scopusqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
Aslan, Ferhat-2014.pdf
Boyut:
96.23Kb
Biçim:
PDF
Açıklama:
Tam Metin / Full Text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster